VIMPAT (lacosamide) tablets are indicated as add-on therapy in the treatment of partial-onset (focal) seizures in patients with epilepsy who are 17 years of age or older. Usually, Vimpat is added when another seizure medicine is not controlling all seizures, rather than being used by itself; however, an experienced physician may choose to try Vimpat as a single medicine in some circumstances.

Use can be in partial-onset seizures with or without secondary generalization to tonic-clonic (previously called grand mal) seizures. This means that seizures may start in one part of the brain (as in a simple or complex partial seizure) or spread to a generalized seizure that may be tonic clonic or grand mal seizure.

VIMPAT (lacosamide) injection for intravenous use is indicated when a person at least 17 years old with partial seizures temporarily cannot take the medicine by mouth. For example, it may be used if a person is very sick or having a surgical procedure. This form of medicine is given through a special atheter or intravenous line that is placed in a person's vein. Special equipment and medical help is needed to give the drug in this way and it is usually done only in hospital settings.